Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes

Rapid Communications in Mass Spectrometry

Volumn 24, Issue 15, 2010, Pages 2245-2254

  Thevis, Mario ^a   Thomas, Andreas ^a   Fußhöller, Gregor ^a   Beuck, Simon ^a   Geyer, Hans ^a   Schänzer, Wilhelm ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; GLUCOSE; HYDROXYLATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETERS; MASS SPECTROMETRY; METABOLITES; SPORTS; SULFUR COMPOUNDS;

ANABOLIC AGENTS; ANDROGEN RECEPTORS; CONTROL PURPOSE; DOPING CONTROL; DRUG CANDIDATES; IN-VITRO; PHASE I; SELECTIVE PROPERTIES; URINARY METABOLITES; WORLD ANTI-DOPING AGENCY;

MODULATORS;

ACETAMIDE DERIVATIVE; AMINOPHENOL DERIVATIVE; ANABOLIC AGENT; ANDARINE; ANDROGEN;

DOPING; EVALUATION STUDY; HUMAN; MALE; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; PREVENTION AND CONTROL; PROCEDURES; SUBSTANCE ABUSE; URINE;

ACETAMIDES; AMINOPHENOLS; ANABOLIC AGENTS; ANDROGENS; DOPING IN SPORTS; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; SUBSTANCE ABUSE DETECTION;

EID: 77955123232     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.4637     Document Type: Article

References (25)

1. Mohler ML, Bohl CE, Narayanan R, He Y, Hwang DJ, Dalton JT, Miller DD. In Nuclear Receptors as Drug Targets, Ottow E, Weinmann H (eds). Wiley-VCH: Weinheim, 2008.
2. Mohler ML, Bohl CE, Jones A, Coss CC, Narayanan R, He Y, Hwang DJ, Dalton JT, Miller DD. J. Med. Chem. 2009; 52: 3597.
3. Bhasin S, Jasuja R. Curr. Opin. Clin. Nutr. Metab. Care 2009; 12: 232.
4. Gao W, Dalton JT. Drug Discov. Today 2007; 12: 241.
5. Kilbourne EJ, Moore WJ, Freedman LP, Nagpal S. Curr. Opin. Investig. Drugs 2007; 8: 821.
6. World Anti-Doping Agency, 2010. Available: http://www.wada-ama.org/Documents/World_Anti-Doping_-Program/WADP-Prohibited-list/WADA_Prohibited_List_2010_EN.pdf (accessed 14-01-2010).
7. Thevis M, Kamber M, Schänzer W. Rapid Commun. Mass Spectrom. 2006; 20: 870.
8. Thevis M, Kohler M, Maurer J, Schlörer N, Kamber M, Schänzer W. Rapid Commun. Mass Spectrom. 2007; 21: 3477.
9. Thevis M, Kohler M, Schlörer N, Fusshöller G, Schänzer W. Eur. J. Mass Spectrom. 2008; 14: 153.
10. Thevis M, Kohler M, Schlörer N, Kamber M, Kuhn A, Linscheid MW, Schänzer W. J. Mass Spectrom. 2008; 43: 639.
11. Thevis M, Kohler M, Thomas A, Maurer J, Schlörer N, Kamber M, Schänzer W. Anal. Bioanal. Chem. 2008; 391: 251.
12. Thevis M, Kohler M, Thomas A, Schlörer N, Schänzer W. Rapid Commun. Mass Spectrom. 2008; 22: 2471.
13. Thevis M, Lohmann W, Schrader Y, Kohler M, Bornatsch W, Karst U, Schänzer W. Eur. J. Mass Spectrom. 2008; 14: 163.
14. Thevis M, Schänzer W. J. Mass Spectrom. 2008; 43: 865.
15. Thevis M, Geyer H, Kamber M, Schänzer W. Drug Test. Anal. 2009; 1: 387.
16. Gao W, Wu Z, Bohl CE, Yang J, Miller DD, Dalton JT. Drug Metab. Dispos. 2006; 34: 243.
17. Kuuranne T, Leinonen A, Schänzer W, Kamber M, Kostiainen R, Thevis M. Drug Metab. Dispos. 2008; 36: 571.
18. Perera MA, Yin D, Wu D, Chan KK, Miller DD, Dalton J. Drug Metab. Dispos. 2006; 34: 1713.
19. Kearbey JD, Wu D, Gao W, Miller DD, Dalton JT. Xenobiotica 2004; 34: 273.
20. Donike M. J. Chromatogr. 1969; 42: 103.
21. Donike M, Zimmermann J. J. Chromatogr. 1980; 202: 483.
22. Sloan S, Harvey DJ, Vouros P. Org. Mass Spectrom. 1971; 5: 789.
23. Diekman J, Thomson JB, Djerassi C. J. Org. Chem. 1967; 32: 3904.
24. Diekman J, Thomson JB, Djerassi C. J. Org. Chem. 1968; 33: 2271.
25. Gray RT, Diekman J, Larson GL, Musker WK, Djerassi C. Org. Mass Spectrom. 1970; 3: 973.